#Japan #Tokyo #cancer detection #N-NOSE #HIROTSU BioScience

N-NOSE: A Unique Cancer Detection Campaign for Father's Day

In an initiative to promote health awareness, HIROTSU BioScience, a Tokyo-based company, is launching a special Father's Day gift campaign centered around their innovative N-NOSE cancer detection test. The campaign, titled "~A Gift of Healthy Habits for Father~ N-NOSE Gift Campaign," aims to encourage people to prioritize their health and the health of their loved ones, especially fathers, during this important occasion.

The campaign runs from May 28, 2025, to June 15, 2025, concluding at 11:59 PM. During this period, individuals who purchase the N-NOSE gift can look forward to receiving a gift certificate for 3,000 yen in rice, which will be sent directly to the purchaser's registered address around early July. This initiative not only recognizes the importance of health monitoring but also pairs it with a thoughtful gift that embodies care and concern for one’s family.

The Importance of Cancer Screening in Japan

Despite Japan being renowned for its advanced medical system, the uptake of cancer screenings remains disappointingly low, particularly among men. According to a study published by Japan's Ministry of Health, Labour and Welfare in 2023, the screening rates for various types of cancer were below the targeted 60%—with only 47.5% for stomach cancer, 53.2% for lung cancer, and 49.1% for colorectal cancer noted in the 2022 survey. This is a concerning statistic that highlights the need for innovative solutions like N-NOSE that can facilitate early cancer detection, ultimately leading to better treatment outcomes.

N-NOSE simplifies the screening process, allowing users to submit urine samples for an accurate analysis of cancer risk. The campaign serves as a gentle reminder of the importance of maintaining health, especially for fathers who often prioritize family well-being over their own.

About HIROTSU BioScience

Founded in August 2016, HIROTSU BioScience has dedicated itself to advancing medical diagnostics through groundbreaking research utilizing the natural abilities of the C. elegans nematode. This innovative approach not only aims to protect public health but also strives to ensure a sustainable future for generations to come. With one in two individuals at risk of developing cancer, the company is committed to developing effective tools for early detection that can surpass traditional methods.

The company’s signature technology, N-NOSE, harnesses the exceptional olfactory capabilities of C. elegans to detect unique odors related to specific cancers found in human urine. This pioneering cancer test is not only convenient, being non-invasive and cost-effective, but also provides comprehensive risk assessments for early-stage cancer diagnosis.

N-NOSE Variants: A Comprehensive Health Solution

HIROTSU BioScience continues to innovate with its N-NOSE lineup:

• - N-NOSE plus: This advanced version specifically identifies cancer types through specially modified nematodes, allowing precise differentiation between different cancer risks, including pancreatic and liver cancers.
• - N-NOSE Animal: This adaptation of N-NOSE caters to pet health, providing owners of dogs and cats with easy-to-administer cancer screening through urine tests. This service aims to fill a crucial gap in veterinary medicine by offering a reliable and straightforward testing method since its launch in 2023.

Conclusion

As Father’s Day approaches, this campaign by HIROTSU BioScience is an excellent opportunity to combine thoughtful gifting with health consciousness. By participating in the N-NOSE Gift Campaign, individuals can express their love and care for their fathers while promoting the crucial practice of regular health check-ups. Take advantage of this special offer, and help ensure a healthier future for those who mean the most to you.

For more information, visit the official campaign page: N-NOSE Gift Campaign and learn more details about the innovative tests available at HIROTSU BioScience.